SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
1.200
-0.040 (-3.23%)
Nov 4, 2026, 11:21 AM EST - Market open
Company Description
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption.
It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice.
The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
SenesTech, Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Dec 8, 2016 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 24 |
| CEO | Michael Edell |
Contact Details
Address: 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 United States | |
| Phone | 928 779 4143 |
| Website | senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R604 |
| ISIN Number | US81720R6045 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Michael Edell | President and Chief Executive Officer |
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
| Jack Karabees | Executive Vice President of Sales |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | SCHEDULE 13G | Filing |
| Oct 30, 2026 | SCHEDULE 13D/A | Filing |
| Oct 26, 2026 | SCHEDULE 13D | Filing |
| Oct 22, 2026 | SCHEDULE 13D/A | Filing |
| Oct 22, 2026 | 8-K | Current Report |
| Oct 19, 2026 | SCHEDULE 13D/A | Filing |
| Oct 15, 2026 | 8-K | Current Report |
| Aug 20, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 6, 2026 | 10-Q | Quarterly Report |
| Aug 5, 2026 | 8-K | Current Report |